TK
Rep. Thomas Kean (R-NJ) bought $1K-$15K of ABT stock
Thomas Kean, U.S. Representative (R-NJ), disclosed a purchase of Abbott Laboratories (ABT) stock worth $1K-$15K in a STOCK Act filing on Aug 20, 2025.
The trade happened on Jul 21, 2025, 30 days before it was made public.
ABT has moved -17.2% since the trade date, from $124.42 to $103.00 (Nov 20, 2026 close).
- Traded
- Jul 21, 2025
- Disclosed
- Aug 20, 2025
- Filing delay
- 30 days
- Price since
- -17.2%
- Source
- STOCK Act disclosure